JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB32529

Anti-S6K1 antibody [E343]

  • KO Validated
  • RabMAb
  • Recombinant
  • Lab Essentials
  • 20ul selling size
  • What is this?

1

(1 Review)

|

(116 Publications)

Rabbit Recombinant Monoclonal KS6B1 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Mouse, Human, Rat samples. Cited in 116 publications.

View Alternative Names

STK14A, Ribosomal protein S6 kinase beta-1, S6K-beta-1, S6K1, 70 kDa ribosomal protein S6 kinase 1, Ribosomal protein S6 kinase I, Serine/threonine-protein kinase 14A, p70 ribosomal S6 kinase alpha, P70S6K1, p70-S6K 1, p70 S6 kinase alpha, p70 S6K-alpha, p70 S6KA

19 Images
Immunocytochemistry/ Immunofluorescence - Anti-S6K1 antibody [E343] (AB32529)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-S6K1 antibody [E343] (AB32529)

Immunocytochemistry/ Immunofluorescence analysis of HeLa (Human epithelial cell line from cervix adenocarcinoma) labeling S6K1 with ab32529 at a dilution of 1/500. Cells were fixed with 4% Paraformaldehyde and permeabilised with 0.1% tritonX-100. ab150077 at 1/1000 was used as the secondary antibody. Nuclei were counterstained with DAPI (blue).

Confocal image showing cytoplamic staining on HeLa cell line.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-S6K1 antibody [E343] (AB32529)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-S6K1 antibody [E343] (AB32529)

Immunohistochemical analysis of Human breast cancer tissue labeling S6K1 with ab32529 at 1/500 dilution (4.4 μg/mL). The secondary antibody used was ImmunoHistoProbe one step HRP Polymer (ready to use). Secondary antibody only control-PBS instead of the primary antibody. Antigen retrieval was heat mediated using ab93684 (Tris/EDTA buffer, pH 9.0). The tissue was counterstained with Hematoxylin.

Immunocytochemistry/ Immunofluorescence - Anti-S6K1 antibody [E343] (AB32529)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-S6K1 antibody [E343] (AB32529)

Immunocytochemistry/Immunofluorescence analysis of MCF 7 (Human breast adenocarcinoma epithelial cell) labeling S6K1 with ab32529 at a dilution of 1 : 200, 11.1 ug/ml. Cells were fixed with 4% Paraformaldehyde and permeabilized with 0.1% Triton X-100. A dilution of 1/1000 (2μg/ml) was used for the secondary antibodyGoat anti rabbit IgG (Alexa Fluor® 488, ab150077). The cells were co-stained at 1 : 200 dilution, 2.5μg/ml with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) . Nuclei counterstained with DAPI (blue). Control : 1 : 1000 dilution.

Flow Cytometry (Intracellular) - Anti-S6K1 antibody [E343] (AB32529)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-S6K1 antibody [E343] (AB32529)

Overlay histogram showing HeLa cells stained with ab32529 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab32529, 1/1000 dilution) for 30 min at 22°C. The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit IgG (H&L) (ab150077) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (0.1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter.

Flow Cytometry (Intracellular) - Anti-S6K1 antibody [E343] (AB32529)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-S6K1 antibody [E343] (AB32529)

Intracellular Flow Cytometry analysis of 293T (Human embryonic kidney epithelial cell) cells labelling with ab32529 (purified) at 1/2200 dilution (1μg/mL) (red). Cells were fixed with 4% paraformaldehyde . Goat anti rabbit IgG (Alexa Fluorr® 488, ab150077) was used as the secondary antibody at 1/2000 dilution. Isotype control - 90% methanol . Unlabeled control - Rabbit monoclonal IgG (ab172730) / Black.

Immunoprecipitation - Anti-S6K1 antibody [E343] (AB32529)
  • IP

Unknown

Immunoprecipitation - Anti-S6K1 antibody [E343] (AB32529)

Lane 1 : HEK293T (Human embryonic kidney epithelial cell) whole cell lysate, 10μg
Lane 2 :
HEK293T whole cell lysate, 10μg and ab32529, 2μg
Lane 3 :
HEK293T cell lysate, 350μg and rabbit IgG (ab172730) , 2μg

Purified ab32529 immunoprecipitating S6K1 in HEK293T cell lysates. Primary antibody was used at a 1/110 dilution (20 μg/ml). For western blotting, ab32529 at 1/500 and VeriBlot for IP (HRP) ab131366 was used for detection at 1/1000 dilution.

Blocking and diluting buffer used : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-S6K1 antibody [E343] (ab32529)

Predicted band size: 59 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-S6K1 antibody [E343] (AB32529)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-S6K1 antibody [E343] (AB32529)

Immunohistochemical analysis of rat brain tissue labeling S6K1 with ab32529 at 1/500 dilution (4.4 μg/mL). The secondary antibody used was ImmunoHistoProbe one step HRP Polymer (ready to use). Secondary antibody only control-PBS instead of the primary antibody. Antigen retrieval was heat mediated using ab93684 (Tris/EDTA buffer, pH 9.0). The tissue was counterstained with Hematoxylin.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-S6K1 antibody [E343] (AB32529)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-S6K1 antibody [E343] (AB32529)

Immunohistochemical analysis of mouse testis tissue labeling S6K1 with ab32529 at 1/500 dilution (4.4 μg/mL). The secondary antibody used was ImmunoHistoProbe one step HRP Polymer (ready to use). Secondary antibody only control-PBS instead of the primary antibody. Antigen retrieval was heat mediated using ab93684 (Tris/EDTA buffer, pH 9.0). The tissue was counterstained with Hematoxylin.

Flow Cytometry (Intracellular) - Anti-S6K1 antibody [E343] (AB32529)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-S6K1 antibody [E343] (AB32529)

Intracellular Flow Cytometry analysis of C6 (Rat glial tumor glial cell) cells labelling with ab32529 (purified) at 1/2200 dilution (1μg/mL) (red). Cells were fixed with 4% paraformaldehyde . Goat anti rabbit IgG (Alexa Fluorr® 488, ab150077) was used as the secondary antibody at 1/2000 dilution. Isotype control - 90% methanol . Unlabeled control - Rabbit monoclonal IgG (ab172730) / Black.

Immunocytochemistry/ Immunofluorescence - Anti-S6K1 antibody [E343] (AB32529)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-S6K1 antibody [E343] (AB32529)

Immunocytochemistry/Immunofluorescence analysis of C6 cells (Rat glial tumor glial cell) labelling S6K1 with ab32529 at a dilution of 1 : 200, 11.1 μg/ml. Cells were fixed with 4% Paraformaldehyde and permeabilized with 0.1% Triton X-100. A 1 : 1000 dilution (2μg/ml) was used for the secondary antibody Goat anti rabbit IgG (Alexa Fluor® 488, ab150077). The cells were co-stained with 1 : 200, 2.5μg/ml with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594). Nuclei counterstained with DAPI (blue). Control : 1 : 1000 dilution.

Flow Cytometry (Intracellular) - Anti-S6K1 antibody [E343] (AB32529)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-S6K1 antibody [E343] (AB32529)

Intracellular Flow Cytometry analysis of Neuro-2a (Mouse neuroblastoma neuroblast) cells labelling with ab32529 (purified) at 1/2200 dilution (1μg/mL) (red). Cells were fixed with 4% paraformaldehyde . Goat anti rabbit IgG (Alexa Fluorr® 488, ab150077) was used as the secondary antibody at 1/2000 dilution. Isotype control - 90% methanol . Unlabeled control - Rabbit monoclonal IgG (ab172730) / Black.

Immunocytochemistry/ Immunofluorescence - Anti-S6K1 antibody [E343] (AB32529)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-S6K1 antibody [E343] (AB32529)

Immunocytochemistry/Immunofluorescence analysis of NIH/3T3 (Mouse embryonic fibroblast) labelling with ab32529 at a dilution of 1 : 200, 11.1 μg/ml. Cells were fixed with 4% Paraformaldehyde and permeabilized with 0.1% Triton X-100. A 1 : 1000 dilution (2μg/ml) was used for the secondary antibody Goat anti rabbit IgG (Alexa Fluor® 488, ab150077). The cells were co-stained at 1 : 200 dilution, 2.5μg/ml with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594). Nuclei counterstained with DAPI (blue). Control : 1 : 1000 dilution.

Immunoprecipitation - Anti-S6K1 antibody [E343] (AB32529)
  • IP

Unknown

Immunoprecipitation - Anti-S6K1 antibody [E343] (AB32529)

Lane 1 : Neuro2a (Mouse neuroblastoma neuroblast) whole cell lysate, 10μg
Lane 2 :
Neuro2a whole cell lysate 350μg and ab32529, 2μg
Lane 3 :
Neuro2a cell lysate, 350μg and rabbit IgG (ab172730), 2μg

Purified ab32529 immunoprecipitating S6K1 in HEK293T cell lysates. Primary antibody was used at a 1/110 dilution (20 μg/ml). For western blotting, ab32529 at 1/500 and VeriBlot for IP (HRP) ab131366 was used for detection at 1/1000 dilution.

Blocking and diluting buffer used : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-S6K1 antibody [E343] (ab32529)

Predicted band size: 59 kDa

false

Western blot - Anti-S6K1 antibody [E343] (AB32529)
  • WB

Supplier Data

Western blot - Anti-S6K1 antibody [E343] (AB32529)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

The identity of the higher MW band at approximately 150 kDa (in lane 2) is unknown.

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.

In Western blot, Anti-RPS6KB1 antibody [E343] (ab32529) staining at 1/1000 dilution.

All lanes:

Western blot - Anti-S6K1 (phospho T389) antibody [EPR24766-9] (<a href='/en-us/products/primary-antibodies/s6k1-phospho-t389-antibody-epr24766-9-ab323272'>ab323272</a>) at 1/1000 dilution

Lane 1:

Untreated HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 50 µg

Lane 2:

Hela treated with 100nM Calycin A for 30min whole cell lysate at 50 µg

Lane 3:

Hela treated with 100nM Calycin A for 30min whole cell lysate (alkaline phosphatase treated membrane) at 50 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 60-80 kDa,36 kDa

false

Exposure time: 37s

Western blot - Anti-S6K1 antibody [E343] (AB32529)
  • WB

Lab

Western blot - Anti-S6K1 antibody [E343] (AB32529)

Western blot : Rabbit Monoclonal[E343] to S6K1 ab32529 staining at 1/10000 dilution, shown in green; Mouse anti GAPDH (ab8245) loading control staining at 1/20,000 dilution, shown in magenta. A band was observed at 59 kDa in Wild-type U-87 MG cell lysates with no signal observed at this size in RPS6KB1 knockout U-87 MG cell line (ab326023). To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20,000 dilution.

All lanes:

Western blot - Anti-S6K1 antibody [E343] (ab32529) at 1/10000 dilution

Lane 1:

Wild-type U-87 MG at 20 µg

Lane 2:

Western blot - Human RPS6KB1 knockout U-87 MG cell line (<a href='/en-us/products/cell-lines/human-rps6kb1-knockout-u-87-mg-cell-line-ab326023'>ab326023</a>) at 20 µg

Lane 2:

RPS6KB1 knockout U-87 MG at 20 µg

Lane 3:

MCF7 at 20 µg

Lane 4:

HEK-293 at 20 µg

Secondary

All lanes:

Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution

Predicted band size: 59 kDa

Observed band size: 59 kDa

false

Western blot - Anti-S6K1 antibody [E343] (AB32529)
  • WB

Lab

Western blot - Anti-S6K1 antibody [E343] (AB32529)

Blocking and diluting buffer used : 5% NFDM/TBST.

All lanes:

Western blot - Anti-S6K1 antibody [E343] (ab32529) at 0.004 µg/mL

Lane 1:

Neuro2a (Mouse neuroblastoma neuroblast) whole cell lysate at 20 µg

Lane 2:

Mouse cerebellum lysate at 20 µg

Lane 3:

C6 (Rat glial tumor glial cell) whole cell lysate at 20 µg

Lane 4:

Rat cerebellum at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 59 kDa

Observed band size: 70 kDa

false

Exposure time: 3min

Western blot - Anti-S6K1 antibody [E343] (AB32529)
  • WB

Lab

Western blot - Anti-S6K1 antibody [E343] (AB32529)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.

In Western blot, Anti-RPS6KB1 antibody [E343] - Total protein control (ab32529) staining at 1/1000 dilution.

The identity of the bands at approximately 150 kDa (in lane 2) and at approximately 30 kDa (in lanes 1-2) are unknown.

All lanes:

Western blot - Anti-S6K1 (phospho T389) antibody [EPR24766-9] (<a href='/en-us/products/primary-antibodies/s6k1-phospho-t389-antibody-epr24766-9-ab323272'>ab323272</a>) at 1/1000 dilution

Lane 1:

Untreated NIH/3T3 (mouse embryonic fibroblast) starved overnight, whole cell lysate at 20 µg

Lane 2:

NIH/3T3 starved overnight, then treated with 100nM Calyculin A for 30min whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/200000 dilution

Observed band size: 60-80 kDa

false

Exposure time: 180s

Western blot - Anti-S6K1 antibody [E343] (AB32529)
  • WB

Unknown

Western blot - Anti-S6K1 antibody [E343] (AB32529)

All lanes:

Western blot - Anti-S6K1 antibody [E343] (ab32529) at 1/10000 dilution

All lanes:

293T cell lysate

Predicted band size: 59 kDa

Observed band size: 70 kDa

false

Western blot - Anti-S6K1 antibody [E343] (AB32529)
  • WB

CiteAb

Western blot - Anti-S6K1 antibody [E343] (AB32529)

S6K1 western blot using anti-S6K1 antibody [E343] ab32529. Publication image and figure legend from Liu, S. C., Hsu, T., et al., 2018, Nat Commun, PubMed 30504771.

ab32529 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab32529 please see the product overview.

Characterization of LIF mutant clones. a Sequence analysis of the LIF gene. Genomic DNA was extracted from parental NPC BM1 cells with wild-type LIF or established clones either with mutations in the signal peptide region of LIF (cLIF clone) or loss of the initiating codon in one allele (LIF+/- clone). The initiating codon within the spacer is indicated in red. Mutated nucleotides are marked in blue. b Assessment of LIF protein expression via western blot using GAPDH as a loading control. c Assessment of secreted LIF using a bead-based cytokine assay. Supernatants were harvested 2 days post culture. Data are presented as means ± SD of triplicate experiments. **p < 0.01, two-tailed, paired t test. d Immunofluorescent detection of LIF (green) in WT, cLIF and LIF+/- cancer cells. Blue, nuclear staining. Scale bars, 10 μm. e Comparison of morphological changes (DIC images) in WT, cLIF, and LIF+/- cancer cells. Scale bars, 10 μm. f Live images of LIF uptake in cancer cells expressing LifeAct-RFP. Recombinant LIF proteins were pre-labeled with ATTO 488 green fluorescent dye. Images were captured 40 min post-LIF addition. g Time-course analysis of LIFR desensitization and p70S6K1 activation in LIF (30 ng/ml)-stimulated cells using GAPDH as a loading control

false

  • Carrier free

    Anti-S6K1 antibody [E343] - BSA and Azide free (Capture)

  • Carrier free

    Anti-S6K1 antibody [E343] - BSA and Azide free

  • HRP

    HRP Anti-S6K1 antibody [E343]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

E343

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

IP, Flow Cyt (Intra), ICC/IF, IHC-P, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

This antibody detects both alpha I and alpha II isoforms.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/110", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000 - 1/10000", "WB-species-notes": "<p>For Rat and Mouse samples 1/500 dilution has only been tried. We have not tested if similarly to Human samples a lot higher dilutions can be used.</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/500", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/100 - 1/2200", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/500", "IHCP-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/110", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000 - 1/10000", "WB-species-notes": "<p>For Rat and Mouse samples 1/500 dilution has only been tried. We have not tested if similarly to Human samples a lot higher dilutions can be used.</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/500", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/100 - 1/2200", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/500", "IHCP-species-notes": "<p></p>" }, "Rat": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000 - 1/10000", "WB-species-notes": "<p>For Rat and Mouse samples 1/500 dilution has only been tried. We have not tested if similarly to Human samples a lot higher dilutions can be used.</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/500", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/100 - 1/2200", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/500", "IHCP-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

S6K1 also known as p70S6K is a serine/threonine kinase involved in protein synthesis. The protein has a molecular weight of approximately 70 kDa. Scientists often examine the presence of S6K1 in various tissues as it is expressed ubiquitously in eukaryotic cells. This kinase plays an instrumental role in the regulation of cell growth proliferation and survival by phosphorylating ribosomal protein S6 and other targets. Researchers explore various cellular contexts where S6K1 activity is implicated due to its widespread expression and function.
Biological function summary

S6K1 functions as a downstream effector of the mammalian target of rapamycin (mTOR) complex specifically mTORC1. S6K1 interacts with several protein complexes enhancing its regulatory capacity in cellular activities. It modulates protein synthesis by phosphorylating substrates involved in translation. By controlling these processes S6K1 aids in cell size regulation and energy metabolism which are critical for maintaining cellular homeostasis and adaptation to nutrient availability.

Pathways

S6K1 plays an essential role in the mTOR signaling pathway a central regulator of cell growth and metabolism. S6K1 functions in close connection with proteins such as mTOR and Raptor within this pathway. Additionally it is involved in the insulin signaling pathway where it works with proteins like insulin receptor substrate (IRS). Both pathways highlight S6K1's role in nutrient sensing and response emphasizing its significance in energy and protein homeostasis.

S6K1 is associated with conditions such as cancer and type 2 diabetes. Dysregulation of S6K1 activity can lead to abnormal cell proliferation contributing to oncogenesis in various cancer types. Specifically altered signaling through pathways involving mTOR and Akt proteins connects S6K1 to cancer progression. In type 2 diabetes S6K1 affects insulin sensitivity where overactive S6K1 signaling leads to insulin resistance. Here interactions with insulin receptor substrate proteins highlight its influence on metabolic disorders underlining its critical role in disease pathology.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression (PubMed : 11500364, PubMed : 12801526, PubMed : 14673156, PubMed : 15071500, PubMed : 15341740, PubMed : 16286006, PubMed : 17052453, PubMed : 17053147, PubMed : 17936702, PubMed : 18952604, PubMed : 19085255, PubMed : 19720745, PubMed : 19935711, PubMed : 19995915, PubMed : 22017876, PubMed : 23429703, PubMed : 28178239). Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD (PubMed : 11500364, PubMed : 12801526, PubMed : 14673156, PubMed : 15071500, PubMed : 15341740, PubMed : 16286006, PubMed : 17052453, PubMed : 17053147, PubMed : 17936702, PubMed : 18952604, PubMed : 19085255, PubMed : 19720745, PubMed : 19935711, PubMed : 19995915, PubMed : 22017876, PubMed : 23429703, PubMed : 28178239). Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex (PubMed : 16286006). Upon mitogenic stimulation, phosphorylation by the mechanistic target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation (PubMed : 16286006). The active form then phosphorylates and activates several substrates in the pre-initiation complex, including the EIF2B complex and the cap-binding complex component EIF4B (PubMed : 16286006). Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis (PubMed : 17053147). Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR (PubMed : 15341740). In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2 (PubMed : 11500364). Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating MAPKAP1/SIN1, MTOR and RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling (PubMed : 15899889, PubMed : 19720745, PubMed : 19935711, PubMed : 19995915). Also involved in feedback regulation of mTORC1 and mTORC2 by phosphorylating DEPTOR (PubMed : 22017876). Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function (By similarity). Phosphorylates mitochondrial URI1 leading to dissociation of a URI1-PPP1CC complex (PubMed : 17936702). The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at Thr-412, which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function (PubMed : 17936702). Mediates TNF-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1 (PubMed : 18952604). In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B (PubMed : 17052453). May be involved in cytoskeletal rearrangement through binding to neurabin (By similarity). Phosphorylates and activates the pyrimidine biosynthesis enzyme CAD, downstream of MTOR (PubMed : 23429703). Following activation by mTORC1, phosphorylates EPRS and thereby plays a key role in fatty acid uptake by adipocytes and also most probably in interferon-gamma-induced translation inhibition (PubMed : 28178239).
See full target information S6K1

Publications (116)

Recent publications for all applications. Explore the full list and refine your search

Molecular pain 21:17448069251376198 PubMed40968661

2025

Inhibition of mTOR/S6K1/Gli1 signaling alleviates morphine-induced thermal hyperalgesia and tolerance.

Applications

Unspecified application

Species

Unspecified reactive species

Xing-He Wang,Long Wang,Long Yang,Yang Bai,Ling-Fei Xu,Miao-Miao Li,Yu-Cheng Liu,Jia Sun,Su Liu

Biomedical reports 22:99 PubMed40297802

2025

Resveratrol ameliorates high‑fat diet‑induced insulin resistance via the DDIT4/mTOR pathway in skeletal muscle.

Applications

Unspecified application

Species

Unspecified reactive species

Xinyan Pan,Gangqiang Xue,Ming Zhao,Ziping Xiang,Dian Liu,Zesen Duan,Chao Wang

Nature communications 16:2923 PubMed40133256

2025

The ER-phagy receptor FAM134B is targeted by Salmonella Typhimurium to promote infection.

Applications

Unspecified application

Species

Unspecified reactive species

Damián Gatica,Reham M Alsaadi,Rayan El Hamra,Boran Li,Rudolf Mueller,Makoto Miyazaki,Qiming Sun,Subash Sad,Ryan C Russell

Cell reports. Medicine 5:101753 PubMed39357525

2024

Leucine restriction ameliorates Fusobacterium nucleatum-driven malignant progression and radioresistance in nasopharyngeal carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Songhe Guo,Shan Xing,ZhenYu Wu,Fangfang Chen,Xiaoyun Pan,Qifan Li,Wanli Liu,Ge Zhang

Frontiers in oncology 14:1418951 PubMed39011477

2024

Pharmacological inhibition of CDK4/6 impairs diffuse pleural mesothelioma 3D spheroid growth and reduces viability of cisplatin-resistant cells.

Applications

Unspecified application

Species

Unspecified reactive species

Aurora Costa,Iris Maria Forte,Francesca Pentimalli,Carmelina Antonella Iannuzzi,Luigi Alfano,Francesca Capone,Rosa Camerlingo,Alessandra Calabrese,Claudia von Arx,Reyes Benot Dominguez,Massimiliano Quintiliani,Michelino De Laurentiis,Andrea Morrione,Antonio Giordano

Frontiers in immunology 14:1268467 PubMed38035098

2023

Palmatine treats urticaria by reducing inflammation and increasing autophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Tian Xiao,Xingzhi Yu,Liping Yang,Xiaohua Duan

JCI insight 8: PubMed37870960

2023

Activation of acetyl-CoA synthetase 2 mediates kidney injury in diabetic nephropathy.

Applications

Unspecified application

Species

Unspecified reactive species

Jian Lu,Xue Qi Li,Pei Pei Chen,Jia Xiu Zhang,Liang Liu,Gui Hua Wang,Xiao Qi Liu,Ting Ting Jiang,Meng Ying Wang,Wen Tao Liu,Xiong Zhong Ruan,Kun Ling Ma

Journal of cellular physiology 238:2827-2840 PubMed37801347

2023

Mutual regulation between GDF11 and TET2 prevents senescence of mesenchymal stem cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jiaming Gao,Hao Wang,Junyan Shen,Xiaojing Liu,Xiaoqi Zhu,Ce Huang,Gongchen Li,Yao Sun,Zhongmin Liu,Yi Eve Sun,Hailiang Liu

Scientific reports 13:14999 PubMed37696922

2023

The amino acid metabolomics signature of differentiating myocardial infarction from strangulation death in mice models.

Applications

Unspecified application

Species

Unspecified reactive species

Song-Jun Wang,Bing-Rui Liu,Fu Zhang,Xiao-Rui Su,Ya-Ping Li,Chen-Teng Yang,Zhi-Hua Zhang,Bin Cong

Molecular medicine reports 28: PubMed37594055

2023

Resveratrol improves palmitic acid‑induced insulin resistance via the DDIT4/mTOR pathway in C2C12 cells.

Applications

Unspecified application

Species

Unspecified reactive species

Xinyan Pan,Chunqiao Liu,Xing Wang,Ming Zhao,Zhimei Zhang,Xuemei Zhang,Chao Wang,Guangyao Song
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com